Regenerative medicine aims to repair, replace, or regenerate damaged tissues using cells, biomaterials, and biologically active molecules. It seeks to restore normal function rather than simply manage symptoms.
In Ophthalmology
Applications include limbal stem cell transplantation, retinal cell therapy, bioengineered corneas, and strategies to protect or regrow optic nerve fibres. Gene and cell therapies, tissue scaffolds, and growth factors all fall under this umbrella.
- Many approaches are in research or early clinical stages
- Corneal and ocular surface disorders have seen the most established applications
- Retinal and optic nerve regeneration remain more challenging
- Close collaboration between scientists, surgeons, and industry drives progress
Implications
Regenerative medicine holds promise for conditions previously considered irreversible causes of blindness. However, widespread clinical adoption requires rigorous evidence and long‑term follow‑up.
- Ethical and regulatory frameworks guide development and patient access
- Patients should be cautious of unproven commercial offerings
- Traditional treatments and rehabilitation remain essential alongside emerging options
- Education about realistic timelines and outcomes is crucial
